share_log

HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $29

HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $29

HC Wainwright & Co.維持對Cullinan Oncology的買入,將目標股價下調至29美元
Moomoo 24/7 ·  04/17 05:36

HC Wainwright & Co. analyst Edward White maintains Cullinan Oncology (NASDAQ:CGEM) with a Buy and lowers the price target from $34 to $29.

HC Wainwright & Co. 分析師愛德華·懷特維持庫裏南腫瘤學(納斯達克股票代碼:CGEM)的買入並將目標股價從34美元下調至29美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論